The table below shows Bolt Biotherapeutics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$8.02M
-$13.37M
-$16.75M
-$23.40M
-$24.31M
-$16.56M
Capital expenditure
-
-
$0.00
$3.00K
$605.00K
$58.00K
Investing cash flow
$7.92M
$14.55M
$10.20M
$28.99M
$40.84M
-$190.52M
Dividends paid
-
-
-
-
BOLT operating cash flow (10-K history)
Bolt Biotherapeutics, Inc. reported operating cash flow of -$39.85M for fiscal year 2025. That is up 35.0% from -$61.29M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from -$47.31M (FY 2020) to -$39.85M. Figures come from the company's audited annual reports as filed with the SEC.